A new lung transplant program at Mayo Clinic is offering renewed hope to patients with advanced lung disease.

However, there is no available information in the literature regarding the prevalence of vitamin D deficiency among patients with diffuse parenchymal lung disease or whether reduced levels are ...

In coal mining communities, black lung has long been considered an “old man’s disease,” one to be almost expected after enough years underground.

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug ...

Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis Date: June 12, 2025 Source: Oregon State University Summary: A scientific team has unlocked a new way to treat serious ...

Sionna's CF drug candidates SION-719 and SION-451 showed strong safety and PK results in Phase 1 trials, advancing to mid-stage studies in 2025.

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first. Insilico Medicine, the biotech company ...

Transpire Bio has licensed an inhaled PDE4 inhibitor from China’s Intragrand Pharma as a potential treatment for idiopathic pulmonary fibrosis.

Trevi's Haduvio met its primary endpoint in a Phase 2b trial for IPF-related chronic cough, with statistically significant results at multiple doses.

Lung biopsy shows Landfried has rare disease Once Landfried's condition stabilized and she was no longer leaking air from her lungs, she returned to Children's Hospital in November for a lung biopsy.

The FDA has slapped Savara with a refuse to file (RTF) letter after the biotech in March applied for approval of molgramostim in the rare disease autoimmune pulmonary alveolar proteinosis (aPAP).